Re: Biogen/Eisai Scrap Aducanumab
in response to
by
posted on
Mar 24, 2019 04:49PM
Would this not be a comparison from baseline to the finality to see if there would be an improvement in cognition for the sub-group by way of MoCA scores?
In a sense, this is not a double-blinded cognition substudy that is being undertaken.
Koo